Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review

References

• World Health Organization. Cardiovascular diseases (CVDs) [Internet]. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
   Google Scholar
• Roth Gregory A, Mensah George A, Johnson Catherine O, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019. J Am Coll Cardiol. 2020;76(25):2982–3021. doi: 10.1016/j.jacc.2020.11.010
   PubMed Web of Science ®Google Scholar
• Luengo-Fernandez R, Leal J, Burns R. P4659Economic burden of CVD across the European Union: trends over the last decade. Eur Heart J. 2017;38(suppl_1):ehx504.P4659. doi: 10.1093/eurheartj/ehx504.P4659
   Google Scholar
• World Health Organization. Regional Office for Europe. Global atlas on cardiovascular disease prevention and control: published by the World Health Organization in collaboration with the World Heart Federation and the World stroke Organization [Internet]. Copenhagen: World Health Organization. Regional Office for Europe; 2011 [cited 2022 Nov 30]. Available from: https://apps.who.int/iris/handle/10665/329516
   Google Scholar
• World Health Organization. Blood pressure/hypertension [Internet]. 2022. Available from: https://www.who.int/data/gho/indicator-metadata-registry/imr-details/3155
   Google Scholar
• World Health Organization. Raised cholesterol [Internet]. 2022. Available from: https://www.who.int/data/gho/indicator-metadata-registry/imr-details/3236
   Google Scholar
• Zodda D, Giammona R, Schifilliti S. Treatment strategy for dyslipidemia in cardiovascular disease prevention: focus on old and New drugs. Pharmacy. 2018;6(1):6. doi: 10.3390/pharmacy6010010
   Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi: 10.1093/eurheartj/ehy339
   PubMed Web of Science ®Google Scholar
• Liberopoulos EN, Florentin M, Mikhailidis DP, et al. Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Expert Opin Drug Saf. 2008;7(6):717–725. doi: 10.1517/14740330802396984
   PubMed Web of Science ®Google Scholar
• Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15. doi: 10.1136/bmj.38875.675486.55
   PubMed Web of Science ®Google Scholar
• Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med care. 2005;43(6):521–530. doi: 10.1097/01.mlr.0000163641.86870.af
   PubMed Web of Science ®Google Scholar
• Souza AC, Borges JW, Moreira TM. Quality of life and treatment adherence in hypertensive patients: systematic review with meta-analysis. Rev Saúde Pública. 2016;50:71. doi: 10.1590/s1518-8787.2016050006415
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens Greenwich Conn. 2008;10(5):348–354. doi: 10.1111/j.1751-7176.2008.07572.x
   PubMed Web of Science ®Google Scholar
• Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074–1090. discussion 1073. doi: 10.1016/S0149-2918(99)80026-5
   PubMed Web of Science ®Google Scholar
• Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:217047. doi: 10.1155/2015/217047
   PubMed Web of Science ®Google Scholar
• Hamdidouche I, Jullien V, Boutouyrie P, et al. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients. J Hypertens. 2017;35(9):1891–1898. doi: 10.1097/HJH.0000000000001402
   PubMed Web of Science ®Google Scholar
• Osula D, Wu B, Schesing K, et al. Comparison of pharmacy refill data with chemical adherence testing in assessing medication nonadherence in a safety net hospital setting. J Am Heart Assoc. 2022;11(19):e027099. doi: 10.1161/JAHA.122.027099
   PubMed Web of Science ®Google Scholar
• Gellad WF, Thorpe CT, Steiner JF, et al. The myths of medication adherence. Pharmacoepidemiol Drug Saf. 2017 [2017 Oct 11];26(12):1437–1441. doi: 10.1002/pds.4334
   PubMed Web of Science ®Google Scholar
• Will JC, Zhang Z, Ritchey MD, et al. Medication adherence and incident preventable hospitalizations for hypertension. Am J Prev Med. 2016;50(4):489–499. doi: 10.1016/j.amepre.2015.08.021
   PubMed Web of Science ®Google Scholar
• Lucas JE, Bazemore TC, Alo C, et al. An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States military health system. PLoS One. 2017;12(11):e0187809. doi: 10.1371/journal.pone.0187809
   PubMed Web of Science ®Google Scholar
• Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34(38):2940–2948. doi: 10.1093/eurheartj/eht295
   PubMed Web of Science ®Google Scholar
• De Vera MA, Bhole V, Burns LC, et al. Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review. Br J Clin Pharmacol. 2014 [2014 Nov 5];78(4):684–698. doi: 10.1111/bcp.12339
   PubMed Web of Science ®Google Scholar
• Feng Y, Zhao Y, Yang X, et al. Adherence to antihypertensive medication and cardiovascular disease events in hypertensive patients: a dose–response meta-analysis of 2 769 700 participants in cohort study. QJM: An International Journal Of Medicine. 2021;115(5):279–286. doi: 10.1093/qjmed/hcaa349
   Web of Science ®Google Scholar
• Sorato MM, Davari M, Kebriaeezadeh A, et al. Reasons for poor blood pressure control in Eastern Sub-Saharan Africa: looking into 4P’s (primary care, professional, patient, and public health policy) for improving blood pressure control: a scoping review. BMC Cardiovasc Disord. 2021;21(1):123. doi: 10.1186/s12872-021-01934-6
   PubMed Web of Science ®Google Scholar
• Tam HL, Wong EML, Cheung K, et al. Effectiveness of text messaging interventions on blood pressure control among patients with hypertension: systematic review of randomized controlled trials. JMIR mHealth uHealth. 2021;9(9):e24527. doi: 10.2196/24527
   PubMed Web of Science ®Google Scholar
• Yao M, Zhou XY, Xu ZJ, et al. The impact of training healthcare professionals’ communication skills on the clinical care of diabetes and hypertension: a systematic review and meta-analysis. BMC Fam Pract. 2021;22(1):152. doi: 10.1186/s12875-021-01504-x
   PubMed Web of Science ®Google Scholar
• Aguiar J, Ribeiro M, Pedro AR, et al. Awareness about barriers to medication adherence in cardiovascular patients and strategies used in clinical practice by Portuguese clinicians: a nationwide study. Int J Clin Pharm. 2021;43(3):629–636. doi: 10.1007/s11096-020-01174-2
   PubMed Web of Science ®Google Scholar
• Van Truong P, Wulan Apriliyasari R, Lin M, et al. Effects of self‐management programs on blood pressure, self‐efficacy, medication adherence and body mass index in older adults with hypertension: Meta‐analysis of randomized controlled trials. Int J Nurs Pract. 2021;27(2):e12920. doi: 10.1111/ijn.12920
   PubMed Web of Science ®Google Scholar
• Tan FCJH, Oka P, Dambha-Miller H, et al. The association between self-efficacy and self-care in essential hypertension: a systematic review. BMC Fam Pract. 2021;22(1):44. doi: 10.1186/s12875-021-01391-2
   PubMed Web of Science ®Google Scholar
• Xu H, Long H. The effect of smartphone app–based interventions for patients with hypertension: systematic review and meta-analysis. JMIR mHealth uHealth. 2020;8(10):e21759. doi: 10.2196/21759
   PubMed Web of Science ®Google Scholar
• Li R, Liang N, Bu F, et al. The effectiveness of self-management of hypertension in adults using mobile health: systematic review and meta-analysis. JMIR mHealth uHealth. 2020;8(3):e17776. doi: 10.2196/17776
   PubMed Web of Science ®Google Scholar
• Hong J, Tiu YC, Leung PYB, et al. Interventions that improve adherence to antihypertensive medications in coronary heart disease patients: a systematic review. Postgrad Med J. 2022;98(1157):219–227. doi: 10.1136/postgradmedj-2020-139116
   PubMed Web of Science ®Google Scholar
• Tan JP, Cheng KKF, Siah RCJ. A systematic review and meta-analysis on the effectiveness of education on medication adherence for patients with hypertension, hyperlipidaemia and diabetes. J Adv Nurs. 2019;75(11):2478–2494. doi: 10.1111/jan.14025
   PubMed Web of Science ®Google Scholar
• Shahaj O, Denneny D, Schwappach A, et al. Supporting self-management for people with hypertension: a meta-review of quantitative and qualitative systematic reviews. J Hypertens. 2019;37(2):264–279. doi: 10.1097/HJH.0000000000001867
   PubMed Web of Science ®Google Scholar
• Cimmaruta D, Lombardi N, Borghi C, et al. Polypill, hypertension and medication adherence: the solution strategy? Int J Cardiol. 2018;252:181–186. doi: 10.1016/j.ijcard.2017.11.075
   PubMed Web of Science ®Google Scholar
• Bramlage P, Ketelhut R, Fronk EM, et al. Clinical impact of patient adherence to a fixed-dose combination of olmesartan, amlodipine and hydrochlorothiazide. Clin Drug Investig. 2014;34(6):403–411. doi: 10.1007/s40261-014-0188-z
   PubMed Web of Science ®Google Scholar
• Bhagavathula AS, Shah SM, Aburawi EH. Medication adherence and treatment-resistant hypertension in newly treated hypertensive patients in the United Arab Emirates. J Clin Med. 2021;10(21):5036. doi: 10.3390/jcm10215036
   PubMed Web of Science ®Google Scholar
• Shani M, Lustman A, Vinker S. Adherence to oral antihypertensive medications, are all medications equal? J Clin Hypertens. 2019;21(2):243–248. doi: 10.1111/jch.13475
   Web of Science ®Google Scholar
• De Jager RL, van Maarseveen EM, Bots ML, et al. Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial. Br J Clin Pharmacol. 2018;84(1):18–24. doi: 10.1111/bcp.13402
   PubMed Web of Science ®Google Scholar
• De Jager RL, De Beus E, Beeftink MMA, et al. Impact of medication adherence on the effect of renal denervation: the SYMPATHY trial. Hypertension. 2017;69(4):678–684. doi: 10.1161/HYPERTENSIONAHA.116.08818
   PubMed Web of Science ®Google Scholar
• Gupta P, Patel P, Štrauch B, et al. Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence. Hypertension. 2017;70(5):1042–1048. doi: 10.1161/HYPERTENSIONAHA.117.09631
   PubMed Web of Science ®Google Scholar
• Kebede B, Chelkeba L, Dessie B, Rate of blood pressure control and its determinants among adult hypertensive patients at Jimma University Medical Center, Ethiopia: prospective cohort study. SAGE Open Med. 2021; 9: doi: 10.1177/20503121211006000
   Web of Science ®Google Scholar
• Wu PH, Yang CY, Yao ZL, et al. Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan. Am J Hypertens. 2009;23(2):155–160. doi: 10.1038/ajh.2009.210
   PubMed Web of Science ®Google Scholar
• Overgaauw N, Alsma J, Brink A, et al. Drug nonadherence is a common but often overlooked cause of hypertensive urgency and emergency at the emergency department. J Hypertens. 2019;37(5):1048–1057. doi: 10.1097/HJH.0000000000002005
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim E, Min KB, et al. Blood pressure and lipid target adherence in Korean patients receiving angiotensin II receptor blockers/statin regimens. Curr Med Res Opin. 2017;33(2):385–390. doi: 10.1080/03007995.2016.1257982
   PubMed Web of Science ®Google Scholar
• Wu JR, Cummings DM, Li Q, et al. The effect of a practice-based multicomponent intervention that includes health coaching on medication adherence and blood pressure control in rural primary care. J Clin Hypertens. 2018;20(4):757–764. doi: 10.1111/jch.13265
   Web of Science ®Google Scholar
• Ewen S, Meyer MR, Cremers B, et al. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis. Clin Res Cardiol. 2015;104(12):1097–1105. doi: 10.1007/s00392-015-0905-5
   PubMed Web of Science ®Google Scholar
• Yang Q, Chang A, Ritchey MD, et al. Antihypertensive medication adherence and risk of cardiovascular disease among older adults: a population-based cohort study. J Am Heart Assoc. 2017;6(6). doi: 10.1161/JAHA.117.006056
   Web of Science ®Google Scholar
• Dragomir A, Côté R, Roy L, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care. 2010;48(5):418–425. doi: 10.1097/MLR.0b013e3181d567bd
   PubMed Web of Science ®Google Scholar
• Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598–1605. doi: 10.1161/CIRCULATIONAHA.108.830299
   PubMed Web of Science ®Google Scholar
• Degli Esposti L, Saragoni S, Benemei S, et al. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clinicoecon Outcomes Res. 2011;3:47–54. doi: 10.2147/CEOR.S15619
   PubMedGoogle Scholar
• Kim J, Bushnell CD, Lee HS, et al. Effect of adherence to antihypertensive medication on the long-term outcome after hemorrhagic stroke in Korea. Hypertension. 2018;72(2):391–398. doi: 10.1161/HYPERTENSIONAHA.118.11139
   PubMed Web of Science ®Google Scholar
• Ho CT, Tung YC, Chou SH, et al. Clinical outcomes in hypertensive patients treated with a single-pill fixed-dose combination of renin-angiotensin system inhibitor and thiazide diuretic. J Clin Hypertens. 2018;20(12):1731–1738. doi: 10.1111/jch.13413
   Web of Science ®Google Scholar
• Bailey JE, Wan JY, Tang J, et al. Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death. J Gen Intern Med. 2010;25(6):495–503. doi: 10.1007/s11606-009-1240-1
   PubMed Web of Science ®Google Scholar
• Tsoi KKF, Wong MCS, Tam WWS, et al. Cardiovascular mortality in hypertensive patients newly prescribed perindopril vs. lisinopril: a 5-year cohort study of 15,622 Chinese subjects. Int J Cardiol. 2014;176(3):703–709. doi: 10.1016/j.ijcard.2014.07.114
   PubMed Web of Science ®Google Scholar
• Lee H, Park JH, Floyd JS, et al. Combined effect of income and medication adherence on mortality in newly treated hypertension: nationwide study of 16 million person-years. J Am Heart Assoc. 2019;8(16). doi: 10.1161/JAHA.119.013148
   Web of Science ®Google Scholar
• Wong MCS, Tam WWS, Wang HHX, et al. Predictors of the incidence of all-cause mortality and deaths due to diabetes and renal diseases among patients newly prescribed antihypertensive agents: a cohort study. Int J Cardiol. 2013;168(5):4705–4710. doi: 10.1016/j.ijcard.2013.07.174
   PubMed Web of Science ®Google Scholar
• Kim S, Shin DW, Yun JM, et al. Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications. Hypertension. 2016 [2016 Feb 13];67:506–512.
   PubMed Web of Science ®Google Scholar
• Campbell PJ, Axon DR, Taylor AM, et al. Hypertension, cholesterol and diabetes medication adherence, health care utilization and expenditure in a medicare supplemental sample. Medicine (Baltimore). 2021;100(35):e27143. doi: 10.1097/MD.0000000000027143
   PubMed Web of Science ®Google Scholar
• Lynch WD, Markosyan K, Melkonian AK, et al. Effect of antihypertensive medication adherence among employees with hypertension. Am J Manag Care. 2009;15(12):871–880.
   PubMed Web of Science ®Google Scholar
• Pittman DG, Tao Z, Chen W, et al. Antihypertensive medication adherence and subsequent healthcare utilization and costs. Am J Manag Care. 2010;16:568–576.
   PubMed Web of Science ®Google Scholar
• Yang Z, Howard DH, Will J, et al. Association of antihypertensive medication adherence with healthcare use and Medicaid expenditures for acute cardiovascular events. Med Care. 2016;54(5):504–511. doi: 10.1097/MLR.0000000000000515
   PubMed Web of Science ®Google Scholar
• Roebuck MC, Liberman JN, Gemmill-Toyama M, et al. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff. 2011;30(1):91–99. doi: 10.1377/hlthaff.2009.1087
   PubMed Web of Science ®Google Scholar
• Kymes SM, Pierce RL, Girdish C, et al. Association among change in medical costs, level of comorbidity, and change in adherence behavior. Am J Manag Care. 2016;22(8):e295–301.
   PubMed Web of Science ®Google Scholar
• Qiao Y, Steve Tsang CC, Hohmeier KC, et al. Association between medication adherence and healthcare costs among patients receiving the low-income subsidy. Value Health. 2020;23(9):1210–1217. doi: 10.1016/j.jval.2020.06.005
   PubMed Web of Science ®Google Scholar
• Campbell PJ, Axon DR, Taylor AM, et al. Associations of renin-angiotensin system antagonist medication adherence and economic outcomes among commercially insured us adults: a retrospective cohort study. J Am Heart Assoc. 2020;9(17). doi: 10.1161/JAHA.119.016094
   Web of Science ®Google Scholar
• Kazerooni R, Watanabe JH, Bounthavong M. Association between statin adherence and cholesterol level reduction from baseline in a veteran population. Pharmacotherapy. 2013;33(10):1044–1052. doi: 10.1002/phar.1305
   PubMed Web of Science ®Google Scholar
• Shalev V, Goldshtein I, Halpern Y, et al. Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings. Pharmacotherapy. 2014;34(1):1–8. doi: 10.1002/phar.1326
   PubMed Web of Science ®Google Scholar
• Yeo SH, Toh MPHS, Lee SH, et al. Impact of medication nonadherence on stroke recurrence and mortality in patients after first-ever ischemic stroke: insights from registry data in Singapore. Pharmacoepidemiol Drug Saf. 2020;29:538–549. doi: 10.1002/pds.4981
   PubMed Web of Science ®Google Scholar
• Hero C, Karlsson SA, Franzén S, et al. Adherence to lipid-lowering therapy and risk for cardiovascular disease and death in type 1 diabetes mellitus: a population-based study from the Swedish national diabetes register. BMJ Open Diabetes Res Care. 2020;8(1):e000719. doi: 10.1136/bmjdrc-2019-000719
   PubMed Web of Science ®Google Scholar
• Perreault S, Ellia L, Dragomir A, et al. Effect of statin adherence on cerebrovascular disease in primary prevention. Am J Med. 2009;122(7):647–655. doi: 10.1016/j.amjmed.2009.01.032
   PubMed Web of Science ®Google Scholar
• Pittman DG, Chen W, Bowlin SJ, et al. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Am J Cardiol. 2011;107(11):1662–1666. doi: 10.1016/j.amjcard.2011.01.052
   PubMed Web of Science ®Google Scholar
• Parati G, Kjeldsen S, Coca A, et al. Adherence to single-pill versus free-equivalent combination therapy in Hypertens Dallas tex 1979: a systematic review and meta-analysis. Hypertension. 2021;77(2):692–705. doi: 10.1161/HYPERTENSIONAHA.120.15781
   PubMed Web of Science ®Google Scholar
• Gallo G, Sarzani R, Cicero AFG, et al. An Expert opinion on the role of the Rosuvastatin/Amlodipine single pill fixed dose combination in cardiovascular prevention. High Blood Press Cardiovasc Prev. 2023;30(2):83–91. doi: 10.1007/s40292-023-00570-9
   PubMed Web of Science ®Google Scholar